Precigen Inc (PGEN)
1.28
-0.01
(-0.78%)
USD |
NASDAQ |
May 10, 16:00
1.28
0.00 (0.00%)
After-Hours: 18:26
Precigen Cash from Operations (TTM): -66.93M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -66.93M |
September 30, 2023 | -66.56M |
June 30, 2023 | -73.36M |
March 31, 2023 | -64.65M |
December 31, 2022 | -65.04M |
September 30, 2022 | -64.24M |
June 30, 2022 | -57.45M |
March 31, 2022 | -58.17M |
December 31, 2021 | -55.77M |
September 30, 2021 | -57.65M |
June 30, 2021 | -59.63M |
March 31, 2021 | -65.66M |
December 31, 2020 | -77.02M |
September 30, 2020 | -33.79M |
June 30, 2020 | -41.93M |
March 31, 2020 | -61.53M |
December 31, 2019 | -77.02M |
September 30, 2019 | -141.15M |
June 30, 2019 | -142.82M |
March 31, 2019 | -137.59M |
December 31, 2018 | -124.24M |
September 30, 2018 | -120.76M |
June 30, 2018 | -113.95M |
Date | Value |
---|---|
March 31, 2018 | -108.92M |
December 31, 2017 | -103.72M |
September 30, 2017 | -87.05M |
June 30, 2017 | -80.77M |
March 31, 2017 | -70.07M |
December 31, 2016 | -48.99M |
September 30, 2016 | -19.45M |
June 30, 2016 | 49.18M |
March 31, 2016 | 45.10M |
December 31, 2015 | 35.67M |
September 30, 2015 | 14.29M |
June 30, 2015 | -45.24M |
March 31, 2015 | -42.38M |
December 31, 2014 | -19.86M |
September 30, 2014 | -21.03M |
June 30, 2014 | -30.24M |
March 31, 2014 | -29.92M |
December 31, 2013 | -53.68M |
September 30, 2013 | -55.79M |
June 30, 2013 | -55.23M |
March 31, 2013 | -62.80M |
December 31, 2012 | -61.53M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-142.82M
Minimum
Jun 2019
-33.79M
Maximum
Sep 2020
-70.02M
Average
-64.65M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Cyclacel Pharmaceuticals Inc | -16.11M |
HealthEquity Inc | 242.83M |
Corvus Pharmaceuticals Inc | -23.94M |
Oragenics Inc | -7.291M |
MAIA Biotechnology Inc | -13.07M |